Author

A. B. Krug

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:flow cytometry· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:proteomics· 1

Frequent Co-Authors

E. Winheim· 3 shared J. Hellmuth· 2 shared J. Kranich· 2 shared K. Lutz· 2 shared L. Rausch· 2 shared L. Rinke· 2 shared M. Muenchhoff· 2 shared S. Rothenfusser· 2 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

E. Winheim

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Prior flavivirus immunity skews the yellow fever vaccine response to expand cross-reactive antibodies with increased risk of antibody dependent enhancement of Zika and dengue virus infection

A. Santos-Peral, F. Luppa, S. Goresch, E. Nikolova, M. Zaucha, L. Lehmann, F. Dahlstroem, H. Karimzadeh, B. M. Kummerer, J. Thorn-Seshold, E. Winheim, G. Dobler, M. Hoelscher, S. Endres, A. B. Krug, , S. Rothenfusser

This study shows that prior TBEV immunity alters the YF17D vaccine response, leading to cross-reactive antibodies that increase the risk of ADE for dengue and Zika.

bioRxiv · May 7, 2023 · PreprintImmunology

Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients

L. Rausch, K. Lutz, M. Schifferer, E. Winheim, R. Gruber, L. Rinke, J. Hellmuth, C. Scheerer, M. Muenchhoff, C. Mandel, M. Bergwelt-Baildon, M. Simons, T. Straub, A. B. Krug, J. Kranich, T. Brocker

The paper identifies PS+ PMPs as a marker for disease severity in COVID-19 by showing their correlation with immune dysfunction and clinical outcomes.

Journal of Extracellular Vesicles · Dec 1, 2021Peer-reviewedImmunology

Impaired function and delayed regeneration of dendritic cells in COVID-19

E. Winheim, L. Rinke, K. Lutz, A. Reischer, A. Leutbecher, L. Wolfram, L. Rausch, J. Kranich, P. R. Wratil, J. Huber, D. Baumjohann, S. Rothenfusser, J. Hellmuth, C. Scherer, M. Muenchhoff, , A. B. Krug

This study examines dendritic cell and monocyte function and regeneration in COVID-19 patients, finding persistent reductions and functional impairments linked to disease severity.

bioRxiv · May 26, 2021 · PreprintImmunology